Octalfa

Rounds

• K KimialysSurface chemistry platform that improves sensitivity of in vitro diagnostic tests $4.2MSeries A · 2 Dec
• V Ventuno BiotechLeadDevelops cancer immunotherapies from a preclinical immuno-oncology pipeline $2.3MSeed · 26 Nov

No round matches these filters.

Often invests with

• Relyens Innovation Santé (Turenne Santé)2
• Angels Santé1
• Armand Bensussan1
• BADGE1
• Evolem1
• Gilles Alberici1
• Odiem Capital1